Analyst initiations 6-14-07: ACV, AMGN, ATHR and B
Posted Jun 14th 2007 11:04AM by Kevin Shult
Filed under: Before the Bell, Amgen Inc (AMGN), Analyst Initiations
MOST NOTEWORTHY: Barnes Group Inc (B), MFA Mortgage Investments (MFA), Alberto-Culver Co (ACV), ZymoGenetics, Inc (ZGEN) and Genelabs Technologies (GNLB) were today's noteworthy initiations:
- CIBC expects Barnes Group (NYSE: B) to benefit from the sustained upswing in the aerospace cycle and robust global execution, starting shares of with a Sector Outperformer rating.
- JMP Securities is positive on MFA Mortgage Investments' (NYSE: MFA) organic yield improvement potential of its short duration portfolio and the company's modest leverage, starting shares with a Market Outperform rating.
- William Blair started shares of Alberto-Culver Co (NYSE: ACV) with an Outperform rating, believing the company is one of the better long-term growth opportunities among mid-cap stocks in consumer products.
- ZymoGenetics Inc (NASDAQ: ZGEN) was started with a Neutral rating at Oppenheimer, since the firm doesn't expect any important new clinical data until Q308.
- Genelabs Technologies Inc (NASDAQ: GNLB) was started with a Buy at Oppenheimer, saying the company has a portfolio of early-stage programs in the treatment of Hep-C that have the potential to be best-in-class...
OTHER INITIATIONS:
- Rodman initiated Amgen, Inc (NASDAQ: AMGN) with a Market Perform rating.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required). Tags: acl, acv, alberto, alcon, amgen, amgn, analyst, atheros, athr, barnes, che, chemed, genelabs, gnlb, initiation, maxy, maxygen, mfa, rating, theflyonthewall.com, zgen, zymogenetics
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
